HEAL Partnership Committee

The HEAL Partnership Committee (HPC) is a subgroup of the HEAL Multi-Disciplinary Working Group (MDWG) and will assist on defined tasks related to the development of new treatments for pain and addiction through HEAL research. The HPC will be responsible for making preliminary recommendations on the design of a template application and evaluation dossier for biopharmaceutical and device-based treatments to be tested through new clinical trials networks as part of HEAL. The MDWG will incorporate input from the HPC into draft recommendations for HEAL research, including the process for the selection of assets for testing, the overall complement of assets to be tested at one time, and the plan for expanding the portfolio to devices and biological treatments. Discussions of the HPC will be made open to the public through videocast and public meetings.

Members of the HEAL Partnership Committee

Christopher Austin
National Center for Advancing Translational Sciences

Rebecca Baker
National Institutes of Health

Patricia Cavazzoni
U.S. Food and Drug Administration

John Dunlop
Amgen

Christopher Flores
Janssen Pharmaceutical Companies of Johnson & Johnson

Steven Joffe
University of Pennsylvania Perelman School of Medicine

Walter Koroshetz
National Institute of Neurological Disorders and Stroke

John Marler
U.S. Food and Drug Administration

Mark Mintun
Lilly

Richard Moscicki
Pharmaceutical Research and Manufacturers of America

Judith Paice
Northwestern University

Kurt Rasmussen
National Institute on Drug Abuse

Cheryl Stucky
Medical College of Wisconsin

Dave Thomas
Biotechnology Innovation Organization

Christin Veasley
Chronic Pain Research Alliance

Kenneth Verburg
Pfizer

Ashley Wittorf
AdvaMed

Clifford Woolf
Harvard Medical School

This page last reviewed on March 8, 2019